Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113918896 | 11391889 | 6 | F | 20160712 | 20150818 | 20160722 | PER | US-TAKEDA-2015TUS010729 | TAKEDA | 0.00 | M | Y | 87.75000 | KG | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113918896 | 11391889 | 1 | PS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | N | 21073 | 45 | MG | |||||||
| 113918896 | 11391889 | 2 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5 MG, UNK | U | 0 | 5 | MG | TABLET | ||||||
| 113918896 | 11391889 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | TABLET | ||||||
| 113918896 | 11391889 | 4 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, UNK | U | 0 | 81 | MG | TABLET | ||||||
| 113918896 | 11391889 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | U | 0 | 500 | MG | TABLET | ||||||
| 113918896 | 11391889 | 6 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 2 MG, UNK | U | 0 | 2 | MG | TABLET | ||||||
| 113918896 | 11391889 | 7 | C | DOXAZOSIN MESYLATE. | DOXAZOSIN MESYLATE | 1 | Oral | 4 MG, UNK | U | 0 | 4 | MG | TABLET | ||||||
| 113918896 | 11391889 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG | TABLET | ||||||
| 113918896 | 11391889 | 9 | C | PYRIDIUM | PHENAZOPYRIDINE | 1 | Oral | 200 MG, TID | U | 0 | 200 | MG | TABLET | TID | |||||
| 113918896 | 11391889 | 10 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, QD | U | 0 | .4 | MG | CAPSULE | QD | |||||
| 113918896 | 11391889 | 11 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113918896 | 11391889 | 1 | Diabetes mellitus |
| 113918896 | 11391889 | 2 | Blood cholesterol increased |
| 113918896 | 11391889 | 5 | Diabetes mellitus |
| 113918896 | 11391889 | 6 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113918896 | 11391889 | Bladder disorder | |
| 113918896 | 11391889 | Haematuria | |
| 113918896 | 11391889 | Pain | |
| 113918896 | 11391889 | Urinary incontinence | |
| 113918896 | 11391889 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113918896 | 11391889 | 1 | 200707 | 201106 | 0 | |
| 113918896 | 11391889 | 6 | 2013 | 0 |